Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles

Journal of Gene Medicine

Volumn 12, Issue 5, 2010, Pages 463-476

  O'Neill, Lee S ^a   Skinner, Amy M ^a   Woodward, Josha A ^a   Kurre, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cell cell transfer; Fibronectin matrix; HIV 1; Lentivirus vector

Indexed keywords

FIBRONECTIN; HEPARIN; LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL HOMING; CELL SURFACE; CELL TRANSFER; EXTRACELLULAR MATRIX; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE; CELL LINEAGE; CELL MEMBRANE; EXTRACELLULAR MATRIX; FIBRONECTINS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPARIN; HUMANS; KINETICS; MICE; PEPTIDE HYDROLASES; PROVIRUSES; RETROVIRIDAE; TIME FACTORS; TRANSDUCTION, GENETIC; VIRION; VIRUS INTEGRATION; VIRUS INTERNALIZATION; WHOLE-BODY IRRADIATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 77952580273     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1458     Document Type: Article

References (57)

1. Lee B, Leslie G, Soilleux E, et al. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001; 75: 12028-12038.
2. Munch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131: 1059-1071.
3. Platt EJ, Durnin JP, Kabat D. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J Virol 2005; 79: 4347-4356.
4. Pais-Correia AM, Sachse M, Guadagnini S, et al. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 2010; 16: 83-89.
5. Andreadis S, Lavery T, Davis HE, et al. Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection. J Virol 2000; 74: 1258-1266.
6. Greco G, Pal S, Pasqualini R, et al. Matrix fibronectin increases HIV stability and infectivity. J Immunol 2002; 168: 5722-5729. (Pubitemid 34556156)
7. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74: 10074-10080.
8. Hanenberg H, Xiao XL, Dilloo D, et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876-882.
9. Davis HE, Morgan JR, Yarmush ML. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 2002; 97: 159-172.
10. Davis HE, Rosinski M, Morgan JR, et al. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 2004; 86: 1234-1242. (Pubitemid 38209565)
11. Sharma S, Miyanohara A, Friedmann T. Separable mechanisms of attachment and cell uptake during retrovirus infection. J Virol 2000; 74: 10790-10795.
12. Le Doux JM, Landazuri N, Yarmush ML, et al. Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Hum Gene Ther 2001; 12: 1611-1621.
13. Pan YW, Scarlett JM, Luoh TT, et al. Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo. J Virol 2007; 81: 639-649.
14. Gothot A, van der Loo JC, Clapp DW, et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641-2649. (Pubitemid 28469074)
15. Kittler EL, Peters SO, Crittenden RB, et al. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood 1997; 90: 865-872.
16. Mazurier F, Gan OI, McKenzie JL, et al. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 2004; 103: 545-552.
17. Copreni E, Castellani S, Palmieri L, et al. Involvement of glycosaminoglycans in vesicular stomatitis virus G glycoprotein pseudotyped lentiviral vector-mediated gene transfer into airway epithelial cells. J Gene Med 2008; 10: 1294-1302.
18. Guibinga GH, Miyanohara A, Esko JD, et al. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol Ther 2002; 5: 538-546.
19. Pizzato M, Blair ED, Fling M, et al. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther 2001; 8: 1088-1096.
20. Walker SJ, Pizzato M, Takeuchi Y, et al. Heparin binds tomurine leukemia virus and inhibits Env-independent attachment and infection. J Virol 2002; 76: 6909-6918.
21. Beer C, Pedersen L. Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol 2007; 81: 8247-8257.
22. Sondergaard CS, Haldrup C, Beer C, et al. Preloading potential of retroviral vectors is packaging cell clone dependent and centrifugation onto CH-296 ensures highest transduction efficiency. Hum Gene Ther 2009; 20: 337-349.
23. Golding H, Zaitseva M, de Rosny E, et al. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J Virol 2002; 76: 6780-6790.
24. Haim H, Steiner I, Panet A. Synchronized infection of cell cultures by magnetically controlled virus. J Virol 2005; 79: 622-625.
25. Murphy SL, Li H, Zhou S, et al. Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver. Mol Ther 2008; 16: 138-145.
26. Kurre P, Anandakumar P, Kiem HP. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Gene Ther 2006; 13: 369-373.
27. McDonald D, Vodicka MA, Lucero G, et al. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002; 159: 441-452.
28. Poli F, Cattaneo R, Crespiatico L, et al. A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing. PCR Methods Appl 1993; 2: 356-358. (Pubitemid 23298981)
29. Nakanishi T, Kuroiwa A, Yamada S, et al. FISH analysis of 142 EGFP transgene integration sites into the mouse genome. Genomics 2002; 80: 564-574.
30. Cole C, Qiao J, Kottke T, et al. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells. Nat Med 2005; 11: 1073-1081.
31. Haim H, Steiner I, Panet A. Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures. J Virol 2007; 81: 3525-3534.
32. Haas DL, Case SS, Crooks GM, et al. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2000; 2: 71-80.
33. Pizzato M, Marlow SA, Blair ED, et al. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol 1999; 73: 8599-8611. (Pubitemid 29441724)
34. Lei P, Bajaj B, Andreadis ST. Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin. J Virol 2002; 76: 8722-8728.
35. Segura MM, Kamen A, Lavoie MC, et al. Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 846: 124-131.
36. Segura MM, Kamen A, Trudel P, et al. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng 2005; 90: 391-404.
37. Toyoshima K, Vogt PK. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 1969; 38: 414-426.
38. Lizee G, Aerts JL, Gonzales MI, et al. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 2003; 14: 497-507.
39. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879-894.
40. Netelenbos T, Zuijderduijn S, Van Den Born J, et al. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol 2002; 72: 353-362.
41. Sadir R, Imberty A, Baleux F, et al. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004; 279: 43854-43860.
42. Gonzalez-Murillo A, Lozano ML, Montini E, et al. Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. Blood 2008; 112: 3138-3147.
43. Laje P, Zoltick PW, Flake AW. SLAM-enriched hematopoietic stem cells maintain long-term repopulating capacity after lentiviral transduction using an abbreviated protocol. Gene Ther 2009; 17: 412-418.
44. Reiser J, Harmison G, Kluepfel-Stahl S, et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 1996; 93: 15266-15271. (Pubitemid 127606378)
45. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 2008; 6: 815-826.
46. Cavrois M, Neidleman J, Kreisberg JF, et al. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 2007; 3: E4.
47. Levine BL, Humeau LM, Boyer J, et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006; 103: 17372-17377.
48. Mostoslavsky G, Kotton DN, Fabian AJ, et al. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 2005; 11: 932-940.
49. Campbell EM, Perez O, Melar M, et al. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 2007; 360: 286-293.
50. Logan AC, Nightingale SJ, Haas DL, et al. Factors influencing the titer and infectivity of lentiviral vectors. Hum Gene Ther 2004; 15: 976-988.
51. Barrette S, Douglas J, Orlic D, et al. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors. Mol Ther 2000; 1: 330-338.
52. Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 2006; 6: 859-868.
53. Yu HJ, Reuter MA, McDonald D. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog 2008; 4: E1000134.
54. Sato H, Orenstein J, Dimitrov D, et al. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992; 186: 712-724.
55. Sourisseau M, Sol-Foulon N, Porrot F, et al. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007; 81: 1000-1012.
56. Platt EJ, Kozak SL, Durnin JP, et al. Rapid HIV-1 Dissociation from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high infectivity of virions. J Virol 2009; 84: 3106-3110.
57. Horiuchi Y, Onodera M, Miyagawa Y, et al. Kinetics and effect of integrin expression on human CD34(+) cells during murine leukemia virus-derived retroviral transduction with recombinant fibronectin for stem cell gene therapy. Hum Gene Ther 2009; 20: 777-783.